Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Inventory (2016)

Viridian Therapeutics, Inc.\DE has reported Inventory over the past 3 years, most recently at $64000.0 for Q4 2016.

  • Quarterly results put Inventory at $64000.0 for Q4 2016, down 65.78% from a year ago — trailing twelve months through Dec 2016 was $64000.0 (down 65.78% YoY), and the annual figure for FY2016 was $64000.0, down 65.78%.
  • Inventory for Q4 2016 was $64000.0 at Viridian Therapeutics, Inc.\DE, up from $62000.0 in the prior quarter.
  • Over the last five years, Inventory for VRDN hit a ceiling of $536000.0 in Q2 2015 and a floor of $62000.0 in Q3 2016.
  • Median Inventory over the past 3 years was $213000.0 (2016), compared with a mean of $239018.5.
  • Biggest five-year swings in Inventory: surged 177.52% in 2015 and later tumbled 82.97% in 2016.
  • Viridian Therapeutics, Inc.\DE's Inventory stood at $179000.0 in 2014, then grew by 4.47% to $187000.0 in 2015, then tumbled by 65.78% to $64000.0 in 2016.
  • The last three reported values for Inventory were $64000.0 (Q4 2016), $62000.0 (Q3 2016), and $213000.0 (Q2 2016) per Business Quant data.